Abstract-Endothelial nitric oxide synthase (eNOS) plays an important role in the control of myocardial oxygen consumption (MVO 2 ) by nitric oxide (NO). A NOS isoform is present in cardiac mitochondria and it is derived from neuronal NOS (nNOS). However, the role of nNOS in the control of MVO 2 remains unknown. MVO 2 in left ventricular tissues from nNOS Ϫ/Ϫ mice was measured in vitro. Stimulation of NO production by bradykinin or carbachol induced a significant reduction in MVO 2 in wild-type (WT) mice. In contrast to WT, bradykinin-or carbachol-induced reduction in MVO 2 was attenuated in nNOS Ϫ/Ϫ . S-methyl-L-thiocitrulline, a potent isoform selective inhibitor of nNOS, had no effect on bradykinin-induced reduction in MVO 2 in WT. Bradykinin-induced reduction in MVO 2 in eNOS Ϫ/Ϫ mice, in which nNOS still exists, was also attenuated. The attenuated bradykinin-induced reduction in MVO 2 in nNOS Ϫ/Ϫ was restored by preincubation with Tiron, ascorbic acid, Tempol, oxypurinol, or SB203850, an inhibitor of p38 kinase, but not apocynin. There was an increase in lucigenin-detectable superoxide anion (O 2 Ϫ ) in cardiac tissues from nNOS
N itric oxide (NO) attenuates mitochondrial respiration by nitrosylating the iron-sulfur centers of aconitase, complexes I and II of the electron transport chain, and through a very potent reversible alteration in the activity of cytochrome c oxidase. [1] [2] [3] We and others have shown that NO can modulate mitochondrial respiration and tissue oxygen consumption in whole body, 4 heart, skeletal muscle, and kidney both in vivo [5] [6] [7] [8] and in vitro. 8 -10 Furthermore, we have shown that NO derived from endothelial NO synthase (eNOS) plays an important role in these processes. 11 Immunohistochemical studies have shown that a NOS is present in the mitochondria. [12] [13] [14] Giulivi et al have provided evidence for the production of NO by intact, purified mitochondria using two spectroscopic techniques. [15] [16] [17] [18] In other laboratories, the production of NO by mitochondria has been shown by formation of L-citrulline from radiolabeled L-arginine. 12, 19, 20 Furthermore, Giulivi et al 17 have reported that mitochondrial NOS was identified as neuronal NOS (nNOS) with two posttranslational modifications in isolated mitochondria from rat liver. Kanai et al 21 identified mitochondrial NOS as nNOS in the isolated cardiac mitochondria from nNOS wild-type (WT) and knockout (nNOS Ϫ/Ϫ ) mice. Thus, nNOS may provide a local source of NO, which can modulate mitochondrial respiration and myocardial oxygen consumption (MVO 2 ). The role of nNOS in the regulation of MVO 2 remains to be elucidated.
French et al 22 showed that the local production of NO by mitochondrial NOS is not significant and does not contribute to the regulation of mitochondrial function using isolated porcine cardiac mitochondria. Our previous study showed that bradykinin (BK) had no inhibitory effect on MVO 2 in tissues obtained from eNOS-deficient mice, in which nNOS still exists. 11 Those data suggest that NO derived from nNOS does not directly contribute to the inhibition of mitochondrial respiration. Very recently, Khan et al 23 have been shown that deficiency of nNOS leads to profound increase in xanthine oxidase (XO)-mediated superoxide anion (O 2 Ϫ ) production without affecting XO mRNA or protein abundance, which depresses myocardial excitation-contraction coupling in a manner reversible by XO inhibition with allopurinol. Thus, we hypothesized that a defect of nNOS increases XO-derived O 2 Ϫ production, which decreases NO bioavailability, and attenuates the control of MVO 2 by NO derived from eNOS.
The goals of our experiments were as follows: (1) to determine whether NO-dependent control of MVO 2 is altered in nNOS Ϫ/Ϫ compared with WT mice; (2) to determine whether O 2 Ϫ production is increased and O 2 Ϫ is associated with NO-dependent control of MVO 2 in nNOS Ϫ/Ϫ ; and (3) to determine the responsible mechanism for O 2 Ϫ production in nNOS Ϫ/Ϫ .
Materials and Methods

Animal Studied
Mice (8 to 10 weeks old) homozygous for targeted disruption of the nNOS gene (nNOS Ϫ/Ϫ , nϭ46), the eNOS gene (eNOS Ϫ/Ϫ , nϭ8), and wild-type control mice (WT, C57BL/6Jϫ129 F2 hybrids, nϭ24) were purchased from Jackson Laboratories (Bar Harbor, Me). All protocols were approved by the Institutional Animal Care and Use Committee of New York Medical College and conform to the current National Institutes of Health and American Physiological Society Guidelines for the Use and Care of Laboratory Animals.
Preparation of Cardiac Muscle Tissues and Measurement of MVO 2
MVO 2 was measured in vitro as we described previously. 11, 24 Mice were anesthetized with pentobarbital sodium (50 mg/kg IP), and hearts were removed immediately. The left ventricle was bisected such that each piece of muscle contained the septum, free wall, and apex. The muscle tissues were incubated in Krebs solution (mol/L: 118 NaCl, 4.7 KCl, 1.5 CaCl 2 , 25 NaHCO 3 , 1.1 MgSO 4 , 1.2 KH 2 PO4, and 5.6 glucose) at 37°C for 2 hours and bubbled continuously with 20% O 2 -5% CO 2 -75% N 2 . Each piece of tissue was placed in a stirred bath with 3 mL of air-saturated Krebs solution containing 10 mmol/L HEPES (pH 7.4). The bath was sealed using a Clark-type platinum oxygen electrode (Yellow Springs Instruments) that was connected to an oxygen monitor (model YSI 5331). Oxygen uptake by tissues was recorded. Tissue respiration was calculated as the rate of decrease in oxygen concentration, assuming an initial oxygen concentration of 224 mol/mL and was expressed as nanomoles of oxygen consumed per minute per gram of tissue. The effect of all drugs on tissue oxygen uptake is expressed as a percentage of change in baseline MVO 2 . 
Experimental Protocols
Effects of Acute Inhibition of nNOS on MVO 2 in WT Mice
To assess the effects of acute inhibition of nNOS, cardiac muscle from WT mice was preincubated with 10 Ϫ5 mol/L S-methyl-Lthiocitrulline (SMTC), a potent isoform selective inhibitor of nNOS, 25 
Immunoblotting for eNOS, iNOS, XO, Phosphorylated p38 Kinase, and Total p38 Kinase Protein in Cardiac Muscle
eNOS, iNOS, XO, phosphorylated p38 kinase, and total p38 kinase protein in cardiac muscle were measured by Western blotting analysis with a monoclonal antibody to eNOS, iNOS (Transduction Laboratories), XO and xanthine dehydrogenase (XDH, NeoMarkers), p38 kinase, and phosphorylated form of p38 kinase (Cell Signaling Technology) followed by densitometry as described previously. 24 ,29 ␤-Actin was used to normalize the amount of protein loaded.
Chemicals
All drugs were purchased from Sigma Chemical Co.
Data Analysis
All data are presented as meanϮSE. Comparisons of O 2 Ϫ production were made using one-way ANOVA followed by Scheffé t test. The changes in MVO 2 caused by BK, CCh, or SNAP were analyzed using repeated measures 2-way ANOVA followed by Scheffé t test. Statistical significance of differences for baseline MVO 2 in cardiac muscle and protein level of XO/XDH, eNOS, iNOS, total p38 kinase, or phosphorylated p38 kinase was determined with unpaired t test. Significant changes were considered at a value of PϽ0.05.
Results
Baseline MVO 2 in WT and nNOSKO Mice
Baseline MVO 2 was not different in any groups in the absence or presence of L-NAME, SMTC, Tempol, ascorbic acid, Tiron, oxypurinol, or apocynin (data not shown) 
Effects of Acute Inhibition of nNOS on MVO 2 in WT Mice
Activation of kinin-B 2 receptors by BK leads to the elevation of intracellular calcium to produce NO through the activation of eNOS. However, this pathway could lead to NO production through the activation of nNOS. To investigate whether NO derived from nNOS directly affect MVO 2 , we examined the effects of SMTC and 7-NI on MVO 2 in WT mice. 10 Ϫ5 mol/L SMTC and 2ϫ10 Ϫ5 mol/L 7-NI had no effect on BK-induced reduction in MVO 2 in WT mice (Figure 2 
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PϭNS). We also investigated the effects of ascorbic acid, another O 2 Ϫ scavenger, or Tempol, a membrane-permeable superoxide anion dismutase mimetic. Again, the attenuated control of MVO 2 in nNOS Ϫ/Ϫ mice was restored by preincubation with either drug ( Figure 3A ).
Effects of Oxypurinol or Apocynin on MVO 2 in nNOS
Ϫ is produced via several mechanisms including xanthine oxidase or NAD(P)H oxidase. Thus, we investigated the effects of oxypurinol, an inhibitor of XO, or apocynin, an inhibitor of NAD(P)H oxidase activation. The attenuated control of MVO 2 in nNOS Ϫ/Ϫ mice was restored by preincubation with oxypurinol ( Figure 3B ), whereas apocynin had no effect on MVO 2 in nNOS Ϫ/Ϫ mice ( Figure 3B ). Furthermore, the restored control of MVO 2 in nNOS Ϫ/Ϫ mice by oxypurinol was attenuated by coincubation of L-NAME (at 10 Ϫ4 mol/L BK, Ϫ30Ϯ2% in nNOS Ϫ/Ϫ with oxypurinol versus Ϫ14Ϯ3% in nNOS Ϫ/Ϫ with oxypurinol and L-NAME; PϽ0.01). BKinduced reduction in MVO 2 in WT mice was not affected by preincubation with oxypurinol (at 10 Ϫ4 mol/L BK, Ϫ26Ϯ2% in WT versus Ϫ26Ϯ2% in WT with oxypurinol; PϭNS).
MVO 2 in WT and eNOS ؊/؊ Mice in Response to BK
To further investigate the role of nNOS in the control of MVO 2 , we examined BK-induced reduction in MVO 2 in eNOS Ϫ/Ϫ mice, in which nNOS still exists. The extent of BK-induced reduction in MVO 2 was significantly less in eNOS Ϫ/Ϫ than WT mice (Figure 4 ). L-NAME had no effect on BK-induced reduction in MVO 2 in eNOS Ϫ/Ϫ mice ( Figure 4 ). In contrast to nNOS Ϫ/Ϫ , the attenuated control of MVO 2 in eNOS Ϫ/Ϫ was not restored by Tiron (Figure 4) .
O 2 ؊ Production in Cardiac Muscle From WT and nNOS ؊/؊ Mice
There was an increase in lucigenin (5ϫ10
Ϫ production in cardiac muscle from nNOS Ϫ/Ϫ compared with WT (336Ϯ16 versus 194Ϯ17 CPM/mg tissue) mice. Tempol decreased O 2 Ϫ in all groups to levels that were not different from each other ( Figure 5 ). SMTC, acute inhibition of nNOS, did not affect O 2 Ϫ production in WT mice ( Figure 5 ). O 2 Ϫ production in nNOS Ϫ/Ϫ mice was decreased by coincubation of oxypurinol, whereas it was unaffected by apocynin or L-NAME ( Figure 5 ). O 2 Ϫ production in WT mice was not affected by coincubation of oxypurinol ( Figure 5) 
eNOS, iNOS, and XO Protein in Cardiac Muscle From WT and nNOS ؊/؊ Mice
There was no difference in eNOS and iNOS protein levels between WT and nNOS Ϫ/Ϫ mice ( Figure 6A and 6B). Bands corresponding to both XO (130 and 100 kDa) and XDH (170 kDa) were present. There were no differences in XO/XDH protein levels between WT and nNOS Ϫ/Ϫ mice ( Figure 6C ).
Phosphorylated Form of p38 Kinase and Total p38 Kinase Protein and the Effect of an Inhibitor of p38 Kinase on MVO 2 and O 2 ؊ Production in Cardiac Muscle From WT and nNOS
Ϫ production in nNOS Ϫ/Ϫ mice was increased, which was inhibited by oxypurinol, an inhibitor of XO. However, we could not find an increase of XO/XDH protein level. Therefore, XO activity is increased in nNOS Ϫ/Ϫ mice, which should be controlled at a posttranslational level. Recently, Kayyali et al 29 have shown that XO/XDH is phosphoprotein, and XO/ XDH is phosphorylated in hypoxic rat pulmonary microvascular endothelial cell through a mechanism involving p38 kinase. First, we investigated whether p38 kinase is activated in heart from nNOS Ϫ/Ϫ mice. Because p38 kinase becomes phosphorylated on activation, antibodies to phosphorylated form of p38 kinase were used. There was an increase in phosphorylated p38 kinase normalized by total p38 kinase protein level in nNOS Ϫ/Ϫ compared with WT mice ( Figure 7A  and 7B) . Next, we examined whether an activation of p38 kinase was associated with the attenuated NO-dependent control of MVO 2 or O 2 Ϫ production in heart from nNOS
mice. The attenuated control of MVO 2 was restored and lucigenin-detectable O 2 Ϫ production was inhibited by prein- 
Discussion
We have demonstrated that BK-or CCh-induced reduction in MVO 2 was attenuated in nNOS Ϫ/Ϫ compared with WT mice. Acute inhibition of nNOS with SMTC or 7-NI did not affect BK-induced reduction in MVO 2 in WT mice. The attenuated control of MVO 2 in nNOS Ϫ/Ϫ mice was restored by preincubation with Tiron, Tempol, ascorbic acid, oxypurinol, or SB203580. There was an increase in lucigenin-detectable O 2 Ϫ production in cardiac muscle from nNOS Ϫ/Ϫ compared with WT mice, which was inhibited by oxypurinol or SB203580. There was no difference in eNOS, iNOS, and XO/XDH protein levels between WT and nNOS Ϫ/Ϫ mice. Very interestingly, there was an increase in phosphorylated p38 kinase protein level in nNOS Ϫ/Ϫ compared with WT mice. Therefore, we concluded that a defect of nNOS attenuated control of MVO 2 by NO derived from another source most likely eNOS, which is associated with an increase in O 2 Ϫ through the activation of XO, and XO was posttranslationally activated through a mechanism involving p38 kinase.
Cardiac nNOS has been found in nerve terminals, 31 cardiac conduction tissue, 32 sarcoplasmic reticulum, 33 and mitochondria. 17, 21 However, the role that the subcellular localization of nNOS plays has not been well understood. For example, nNOS, probably in sarcoplasmic reticulum, plays an important role in the control of myocardial contraction and calcium cycling. 34, 35 Sears et al 35 have reported that nNOS suppresses sarcoplasmic reticulum calcium release, and Khan et al 34 have reported that nNOS plays a primary role in stimulating sarcoplasmic reticulum calcium cycling. In this regard, the role of nNOS remains highly controversial. Giulivi et al have provided evidence for the production of NO by intact, 
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؊/؊ Micepurified mitochondria using two spectroscopic techniques, 15, 16, 18 and they have identified mitochondrial NOS as a nNOS with two posttranslational modifications in isolated mitochondria from rat liver. 17 Kanai et al 21 showed the similarity between mitochondrial NOS and nNOS in a study performed on isolated cardiac mitochondria from WT and nNOS Ϫ/Ϫ mice. Given that the subcellular localization of nNOS exists in proximity to the regulatory site of MVO 2 , nNOS may play an important role in the regulation of MVO 2 .
We demonstrated that BK-induced reduction in MVO 2 was attenuated in nNOS Ϫ/Ϫ compared with WT mice. L-NAME inhibited BK-induced reduction in MVO 2 in WT mice, whereas it did not affect that in nNOS Ϫ/Ϫ (data not shown). These results suggest that NO-dependent control of MVO 2 is attenuated in nNOS Ϫ/Ϫ . We have reported that eNOS plays an important role in NO-dependent control of MVO 2 . 11 We examined whether eNOS protein is decreased in nNOS Ϫ/Ϫ mice. We could not find any differences in the expression of eNOS protein between WT and nNOS Ϫ/Ϫ mice. We also used CCh, whose effect is mediated by muscarinic receptors, to stimulate endogenous NO production. Again, CCh-induced reduction in MVO 2 was attenuated in nNOS Ϫ/Ϫ compared with WT. This does not suggest that the function of receptors mediating release of NO is altered in nNOS Ϫ/Ϫ mice. Furthermore, there was no difference in SNAP-induced reduction in MVO 2 between nNOS Ϫ/Ϫ and WT mice, suggesting that the mitochondrial function in heart from nNOS Ϫ/Ϫ mice is normal.
Activation of kinin-B 2 receptors by BK or muscarinic receptors by CCh leads to the elevation of intracellular calcium to produce NO through the activation of eNOS. However, this pathway could lead to NO production through the activation of nNOS. The attenuated NO-dependent control of MVO 2 in nNOS Ϫ/Ϫ mice might be attributable to the lack of NO production derived from nNOS. We investigated the effects of SMTC and 7-NI on MVO 2 in WT mice. In WT mice, 10 Ϫ5 mol/L SMTC and 2ϫ10 Ϫ5 mol/L 7-NI had no effect on MVO 2 . 7-NI has been shown to be relatively selective inhibitor of nNOS. 26 
2ϫ10
Ϫ5 mol/L 7-NI attenuated the response to transmural electrical stimulation and to nicotine by 50%, but did not alter the endothelium-dependent relaxation in response to histamine in isolated cerebral arteries from monkey. 26 SMTC is a more potent selective inhibitor of nNOS than 7-NI. SMTC is 17-fold selective for rat nNOS in neuronal tissue compared with rat eNOS in vascular endothelium, 25 and 10 Ϫ5 mol/L SMTC almost completely inhibits nNOS in rat cortical slices. 25 In preliminary experiments, we also investigated the effects of 10 Ϫ4 mol/L SMTC on MVO 2 in WT mice. Also in WT mice, 10 Ϫ4 mol/L SMTC attenuated BK-induced reduction in MVO 2 (data not shown). This result suggests that SMTC can enter cells and have pharmacological effects in heart tissue, because high concentrations of SMTC inhibit eNOS in rat aortic ring. 25 Therefore, these results suggest that the attenuated NOdependent control of MVO 2 in nNOS Ϫ/Ϫ mice is not attributable to the lack of NO production derived from nNOS. Furthermore, we also examined BK-induced reduction in MVO 2 in eNOS Ϫ/Ϫ mice, in which nNOS still exists. The extent of BK-induced reduction in MVO 2 was significantly less in eNOS Ϫ/Ϫ than WT mice and L-NAME had no effect on BK-induced reduction in MVO 2 in eNOS Ϫ/Ϫ mice. These results suggest that NO production from nNOS is not responsible for the control of MVO 2 . This finding is compatible with studies by French et al and us. 11, 22 Recently, we have reported that NO-dependent control of MVO 2 was attenuated in heterozygous manganese superoxide anion dismutase mice and was reversed by the freely membrane permeable O 2 Ϫ scavenger Tiron. 24 Ϫ is produced via several mechanisms including XO, NAD(P)H oxidase, or eNOS. The attenuated NO-dependent control of MVO 2 in nNOS Ϫ/Ϫ mice was restored by oxypurinol, but not apocynin. Furthermore, the increase in lucigenindetectable O 2 Ϫ in nNOS Ϫ/Ϫ mice was also inhibited by oxypurinol, but not by apocynin or L-NAME. These results strongly suggest that O 2 Ϫ , which is produced through the activation of XO, plays an important role in the attenuation of NO-dependent control of MVO 2 in nNOS Ϫ/Ϫ mice. We also investigated the expression of XO/XDH protein by Western blotting using commercially available monoclonal antibody. There was no difference in XO/XDH protein level between WT and nNOS Ϫ/Ϫ mice. Therefore, the increased production of O 2 Ϫ is attributable to an increase in XO activity, which should be controlled at a posttranslational level.
Khan et al 23 have reported that XO-mediated O 2 Ϫ production is increase in nNOS Ϫ/Ϫ without affecting XO mRNA and protein abundance, and enhanced XO activity inhibits myocyte contractility in nNOS Ϫ/Ϫ . They concluded that nNOS directly interacts with XO and represents an important antioxidant system, inhibiting XO activity. 23 On the other hand, recently, Kayyali et al 29 have shown that XO/XDH is phosphorylated and the activity of XO is increased in hypoxic rat pulmonary microvascular endothelial cell through a mechanism involving p38 kinase. Thus, we hypothesized that an increase in O 2 Ϫ production through the activation of XO in nNOS Ϫ/Ϫ is associated with p38 kinase pathway. There was an increase in phosphorylated p38 kinase protein level in nNOS Ϫ/Ϫ compared with WT mice, whereas there was no difference in total p38 kinase protein level between nNOS Ϫ/Ϫ and WT mice. Furthermore, the attenuated control of MVO 2 was restored and lucigenin-detectable O 2 Ϫ production was Figure 8 . Schematic representation of potential mechanisms responsible for the reduced NO-dependent control of MVO 2 in cardiac muscle from nNOS Ϫ/Ϫ mice. Chronic deletion of nNOS 1 leads to the activation of p38 kinase, and XO is activated through a mechanism involving p38 kinase. NO is inactivated by an increase in O 2 Ϫ production through the activation of XO, and NO-dependent control of MVO 2 is attenuated. On the other hand, acute pharmacological inhibition of nNOS do not affect these pathways (dashed line).
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